Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy

被引:3
|
作者
Zhong, Kaihang [1 ]
Xu, Yuyan [1 ]
Cheng, Yuan [1 ]
Wen, Yaohong [1 ]
Cai, Lei [1 ]
He, Guolin [1 ]
Huang, Huakun [1 ]
Fu, Shunjun [1 ]
Zhong, Xuefeng [2 ]
Zheng, Yating [2 ]
Chen, Tingting [2 ]
Huang, Mengli [2 ]
Pan, Mingxin [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Gen Surg Ctr, Dept Hepatobiliary Surg 2, Guangzhou, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma (HCC); portal vein tumor thrombus (PVTT); tumor immune microenvironment (TIME); tertiary lymphoid structure (TLS); combined immunotherapy; B-CELLS; SURVIVAL; SORAFENIB; RESECTION;
D O I
10.3389/fimmu.2022.999763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portal vein tumor thrombus (PVTT) is a frequent complication in hepatocellular carcinoma (HCC). HCC patients with PVTT have the characteristics of less treatment tolerance and poor prognosis. Immunotherapy, especially combined immunotherapy, has been successfully used in advanced HCC. However, there are no recognized universally indicators that can predict response or resistance to immunotherapy for HCC. Herein, we reported a 58-year-old HCC patient with PVTT, cirrhosis and chronic viral hepatitis, who achieved complete response (CR) after combined immunotherapy (camrelizumab combined with sorafenib or regorafenib), according to his high enrichment of tumor-infiltrating immune cells and tertiary lymphoid structure (TLS). In this case, we revealed the characteristics of the baseline tumor immune microenvironment (TIME) in a HCC patient who responded well to combined immunotherapy, suggesting that TIME can be used to assist in clinical decision making of immunotherapy for HCC.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
    Shiozawa, Kazue
    Watanabe, Manabu
    Ikehara, Takashi
    Matsukiyo, Yasushi
    Kogame, Michio
    Kanayama, Masahiro
    Matsui, Teppei
    Kikuchi, Yoshinori
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    ONCOLOGY LETTERS, 2014, 7 (01) : 50 - 52
  • [2] Hepatocellular carcinoma with portal vein tumor thrombus - Response
    Furuse, J
    Iwasaki, M
    Yoshino, M
    Konishi, M
    Kawano, N
    Kinoshita, T
    Ryu, M
    Satake, M
    Moriyama, N
    RADIOLOGY, 1998, 207 (02) : 553 - 553
  • [3] Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report
    Chen, Xianli
    Liu, Liguan
    Pan, Xingnan
    ONCOLOGY LETTERS, 2015, 9 (06) : 2495 - 2498
  • [4] Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus
    Iiai, T
    Sato, Y
    Nabatame, N
    Yamamoto, S
    Makino, S
    Hatakeyama, K
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1628 - 1630
  • [5] The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
    Luo, Fangzhou
    Li, Mengxia
    Ding, Jun
    Zheng, Shusen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Shi, Jie
    Lai, Eric C. H.
    Li, Nan
    Guo, Wei-Xing
    Xue, Jie
    Lau, Wan Yee
    Wu, Meng-Chao
    Cheng, Shu-Qun
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2073 - 2080
  • [7] Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
    JuXian Sun
    Jie Shi
    Nan Li
    WeiXing Guo
    MengChao Wu
    WanYee Lau
    ShuQun Cheng
    Cancer Biology & Medicine, 2016, 13 (04) : 452 - 458
  • [8] Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
    Masami Minagawa
    Masatoshi Makuuchi
    World Journal of Gastroenterology, 2006, (47) : 7561 - 7567
  • [9] Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
    Sun, Ju-Xian
    Shi, Jie
    Li, Nan
    Guo, Wei-Xing
    Wu, Meng-Chao
    Lau, Wan-Yee
    Cheng, Shu-Qun
    CANCER BIOLOGY & MEDICINE, 2016, 13 (04) : 452 - 458
  • [10] Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
    Minagawa, Masami
    Makuuchi, Masatoshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (47) : 7561 - 7567